Relmada Therapeutics Inc (RLMD)
3.35
-0.14
(-4.01%)
USD |
NASDAQ |
May 17, 16:00
3.35
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Cash and Short Term Investments (Quarterly): 83.61M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 83.61M |
| December 31, 2023 | 96.32M |
| September 30, 2023 | 106.27M |
| June 30, 2023 | 118.53M |
| March 31, 2023 | 132.44M |
| December 31, 2022 | 148.32M |
| September 30, 2022 | 184.15M |
| June 30, 2022 | 211.96M |
| March 31, 2022 | 220.65M |
| December 31, 2021 | 211.91M |
| September 30, 2021 | 88.09M |
| June 30, 2021 | 109.07M |
| March 31, 2021 | 102.70M |
| December 31, 2020 | 117.09M |
| September 30, 2020 | 123.14M |
| June 30, 2020 | 134.09M |
| March 31, 2020 | 114.92M |
| September 30, 2019 | 7.850M |
| June 30, 2019 | 9.217M |
| March 31, 2019 | 2.054M |
| December 31, 2018 | 2.427M |
| September 30, 2018 | 0.8875M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.239M |
| March 31, 2018 | 4.258M |
| December 31, 2017 | 5.940M |
| September 30, 2017 | 4.685M |
| June 30, 2017 | 1.710M |
| March 31, 2017 | 2.757M |
| December 31, 2016 | 4.714M |
| September 30, 2016 | 6.222M |
| June 30, 2016 | 8.500M |
| March 31, 2016 | 11.35M |
| December 31, 2015 | 15.13M |
| September 30, 2015 | 19.17M |
| June 30, 2015 | 22.47M |
| March 31, 2015 | 26.96M |
| December 31, 2014 | 31.42M |
| September 30, 2014 | 27.39M |
| February 28, 2014 | 0.0026M |
| November 30, 2013 | 0.0062M |
| August 31, 2013 | 0.0153M |
| May 31, 2013 | 0.0007M |
| February 28, 2013 | 0.0075M |
| August 31, 2012 | 0.0089M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
7.850M
Minimum
Sep 2019
220.65M
Maximum
Mar 2022
122.12M
Average
117.09M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.378M |
| Lifecore Biomedical Inc | 19.09M |
| Harrow Inc | 75.97M |
| Corvus Pharmaceuticals Inc | 22.13M |
| Aquestive Therapeutics Inc | 95.20M |